Home › NDC Lookup › RxCUI directory › RxCUI 1657007

40 ML ipilimumab 5 MG/ML Injection [Yervoy] — RxCUI 1657007

Name: 40 ML ipilimumab 5 MG/ML Injection [Yervoy] (RxCUI 1657007)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1657007 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1657007

Official name40 ML ipilimumab 5 MG/ML Injection [Yervoy]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asYervoy 200 MG per 40 ML Injection; Yervoy 200 MG in 40 ML Injection

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)3,521 prescriptions · 39 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ipilimumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Yervoy (ipilimumab) is an immunotherapy — it helps your own immune system recognize and attack cancer cells. Your doctor prescribed it because it's approved to treat several advanc...
What exactly is Yervoy and why did my doctor prescribe it?
Yervoy is given as an IV infusion — a slow drip into a vein — at a clinic or infusion center by a trained healthcare professional. Each session takes about 30 minutes. Depending on...
How will I receive this medication, and how often do I come in?

📖 Read our full Ipilimumab Injection guide →

🕸️ Concept Web — How 40 ML ipilimumab 5 MG/ML Injection [Yervoy] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 40 ML ipilimumab 5 MG/ML Injection [Yervoy] RxCUI 1657007 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Ipilimumab 1094833 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Yervoy 1094837 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Ipilimumab Injection 1657004 SCDF
- Ipilimumab Injectable Product 1161327 SCDG
- Ipilimumab Injection [Yervoy] 1657006 SBDF
- Yervoy Injectable Product 1186646 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 40 ML ipilimumab 5 MG/ML Injection 1657005 SCD
- Ipilimumab 5 MG/ML 1094834 SCDC
- Ipilimumab 5 MG/ML [Yervoy] 1094838 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

40 ML ipilimumab 5 MG/ML Injection SCD · 1657005
Ipilimumab 5 MG/ML SCDC · 1094834
Ipilimumab Injection SCDF · 1657004
Ipilimumab Injectable Product SCDG · 1161327

Brand-Name Concepts

Ipilimumab 5 MG/ML [Yervoy] SBDC · 1094838
Ipilimumab Injection [Yervoy] SBDF · 1657006
Yervoy Injectable Product SBDG · 1186646
Yervoy BN · 1094837

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 1657007 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00003-2327-11	1 VIAL, SINGLE-USE in 1 CARTON (0003-2327-11) / 10 mL in 1...	YERVOY	E.R. Squibb & Sons, L.L.C.	2011-03-25
00003-2328-22	1 VIAL, SINGLE-USE in 1 CARTON (0003-2328-22) / 40 mL in 1...	YERVOY	E.R. Squibb & Sons, L.L.C.	2011-03-25

Observed labelers: E.R. Squibb & Sons, L.L.C. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9228	Ipilimumab injection	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.